Novo Nordisk Hunts for Deals After Losing Metsera to Pfizer
Novo Nordisk CEO says company is open to acquisitions of any size to strengthen its obesity drug portfolio following competition from Eli Lilly and loss of Metsera to Pfizer.
NOTRELOAD AI
Biogen Reports $222M R&D Charge Impact on Q4 2025 Earnings
Biogen discloses $222 million charge for research partnerships and licensing agreements, reducing Q4 2025 earnings by $1.26 per share in SEC filing.
Tesla Ditches One-Time FSD Purchase, Goes Subscription-Only
Tesla ends lifetime Full Self-Driving purchases after Feb 14, 2026, switching to subscription-only model as vehicle sales slow and recurring revenue becomes priority.
BARK Stock Jumps on Competing $1.10 Buyout Offer
BARK stock surges as GNK Holdings and Marcus Lemonis submit $1.10/share buyout offer, topping Great Dane Ventures' previous bid by 22%.
Trump Hints at Apple's Possible Intel Investment: What We Know
President Trump suggests Apple may have invested in Intel alongside the U.S. government's 10% stake, but details remain unclear without official confirmation from either company.
Glaukos Stock Drops on Slower iDose Growth Despite Strong Q4 Results
Glaukos shares fell 9% after Q4 iDose sales growth disappointed investors, though the company maintained its 2026 revenue guidance of $600-620 million.